{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:28:01Z","timestamp":1754162881239,"version":"3.41.2"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>This article reviews recent developments in methods used to monitor paediatric type 1 diabetes (T1D), including an examination of the role of glycated haemoglobin (haemoglobin A1c) and its limitations for long-term assessment of glycaemia in individual patients, self-monitoring of blood glucose, continuous glucose monitoring (CGM) systems and ketone monitoring.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Monitoring of glycemia and ketones, when indicated, is a cornerstone of paediatric T1D management and is essential to optimize glycaemic control. Ongoing technological advancements have led to rapid changes and considerable improvement in the methods used to monitor glucose concentrations in people with T1D. As a result of recent innovations that have enhanced accuracy and usability, CGM is now considered the optimal method for monitoring glucose concentrations and should be introduced soon after diagnosis of T1D.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Patients\/families and healthcare providers must receive comprehensive education and proper training in the use of CGM and interpretation of the vast amounts of data. Future challenges include ensuring equal access to and optimizing clinical use of CGM to further improve T1D care and outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000001136","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T02:01:22Z","timestamp":1657850482000},"page":"391-399","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Monitoring of paediatric type 1 diabetes"],"prefix":"10.1097","volume":"34","author":[{"given":"Brynn E.","family":"Marks","sequence":"first","affiliation":[{"name":"Children's National Hospital, Division of Endocrinology, Washington, District of Columbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph I.","family":"Wolfsdorf","sequence":"additional","affiliation":[{"name":"Boston Children's Hospital, Division of Endocrinology, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"(Suppl 1)","key":"R1-20250730","first-page":"S208","article-title":"14 children and adolescents: Standards of Medical Care in Diabetes","volume":"45","author":"Draznin","year":"2022","journal-title":"Diabetes Care"},{"key":"R2-20250730","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2337\/dc17-0636","article-title":"The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading","volume":"40","author":"Beck","year":"2017","journal-title":"Diabetes Care"},{"key":"R3-20250730","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/1932296818822496","article-title":"The relationships between time in range, hyperglycemia metrics, and HbA1c","volume":"13","author":"Beck","year":"2019","journal-title":"J Diabetes Sci Technol"},{"key":"R4-20250730","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1182\/blood-2008-04-154112","article-title":"Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c","volume":"112","author":"Cohen","year":"2008","journal-title":"Blood"},{"key":"R5-20250730","doi-asserted-by":"crossref","first-page":"359ra130","DOI":"10.1126\/scitranslmed.aaf9304","article-title":"Mechanistic modeling of hemoglobin glycation and red blood cell kinetics enables personalized diabetes monitoring","volume":"8","author":"Malka","year":"2016","journal-title":"Sci Transl Med"},{"key":"R6-20250730","doi-asserted-by":"crossref","first-page":"95","DOI":"10.7326\/M16-2596","article-title":"Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels","volume":"167","author":"Bergenstal","year":"2017","journal-title":"Ann Intern Med"},{"key":"R7-20250730","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1089\/dia.2017.0455","article-title":"Optimal sampling duration for continuous glucose monitoring to determine long-term glycemic control","volume":"20","author":"Riddlesworth","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"R8-20250730","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2337\/dc10-1661","article-title":"Persistence of individual variations in glycated hemoglobin: analysis of data from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Trial","volume":"34","author":"Wilson","year":"2011","journal-title":"Diabetes Care"},{"key":"R9-20250730","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.2337\/dc10-1767","article-title":"Evidence for consistency of the glycation gap in diabetes","volume":"34","author":"Nayak","year":"2011","journal-title":"Diabetes Care"},{"key":"R10-20250730","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.2337\/dc11-2450","article-title":"Estimation of the glycation gap in diabetic patients with stable glycemic control","volume":"35","author":"Rodriguez-Segade","year":"2012","journal-title":"Diabetes Care"},{"key":"R11-20250730","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4158\/EP13079.OR","article-title":"Hemoglobin A1C, mean glucose, and persistence of glycation ratios in insulin-treated diabetes","volume":"20","author":"Argento","year":"2014","journal-title":"Endocr Pract"},{"key":"R12-20250730","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/dme.14110","article-title":"HbA1c determination from HemaSpot blood collection devices: comparison of home prepared dried blood spots with standard venous blood analysis","volume":"37","author":"Hall","year":"2020","journal-title":"Diabet Med"},{"key":"R13-20250730","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/dia.2021.0023","article-title":"An evaluation of two capillary sample collection kits for laboratory measurement of HbA1c","volume":"23","author":"Beck","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"R14-20250730","doi-asserted-by":"crossref","first-page":"e002527","DOI":"10.1136\/bmjdrc-2021-002527","article-title":"Validation and feasibility of a postal system for remote monitoring of HbA1c","volume":"9","author":"Cross","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"R15-20250730","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1399-5448.2010.00650.x","article-title":"Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes","volume":"12","author":"Ziegler","year":"2011","journal-title":"Pediatr Diabetes"},{"key":"R16-20250730","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.2337\/dc12-1770","article-title":"Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants","volume":"36","author":"Miller","year":"2013","journal-title":"Diabetes Care"},{"key":"R17-20250730","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.pcd.2021.05.006","article-title":"Blood glucose monitoring (BGM) still matters for many: associations of BGM frequency and glycemic control in youth with type 1 diabetes","volume":"15","author":"Ortiz La Banca","year":"2021","journal-title":"Prim Care Diabetes"},{"issue":"(Suppl 1)","key":"R18-20250730","first-page":"S97","article-title":"7 Diabetes technology: Standards of Medical Care in Diabetes","volume":"45","author":"Draznin","year":"2022","journal-title":"Diabetes Care"},{"key":"R19-20250730","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/dia.2014.0272","article-title":"Assessing sensor accuracy for nonadjunct use of continuous glucose monitoring","volume":"17","author":"Kovatchev","year":"2015","journal-title":"Diabetes Technol Ther"},{"key":"R20-20250730","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time in Range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"R21-20250730","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.2337\/dc20-0112","article-title":"Real-time CGM is superior to flash glucose monitoring for glucose control in type 1 diabetes: the CORRIDA Randomized Controlled Trial","volume":"43","author":"Haskova","year":"2020","journal-title":"Diabetes Care"},{"key":"R22-20250730","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/S0140-6736(21)00789-3","article-title":"Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial","volume":"397","author":"Visser","year":"2021","journal-title":"Lancet"},{"key":"R23-20250730","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/1932296814554797","article-title":"Time lag of glucose from intravascular to interstitial compartment in type 1 diabetes","volume":"9","author":"Basu","year":"2015","journal-title":"J Diabetes Sci Technol"},{"key":"R24-20250730","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/dia.2018.0364","article-title":"Lag time remains with newer real-time continuous glucose monitoring technology during aerobic exercise in adults living with Type 1 diabetes","volume":"21","author":"Zaharieva","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"R25-20250730","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1089\/dia.2022.0011","article-title":"Accuracy and safety of Dexcom G7 continuous glucose monitoring in adults with diabetes","volume":"24","author":"Garg","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"R26-20250730","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1177\/1932296820920948","article-title":"Safety and functional integrity of continuous glucose monitoring components after simulated radiologic procedures","volume":"15","author":"Thomas","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"R27-20250730","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1089\/dia.2021.0182","article-title":"Evaluation of accuracy and safety of the next-generation up to 180-day long-term implantable Eversense continuous glucose monitoring system: the PROMISE Study","volume":"24","author":"Garg","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"R28-20250730","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.2337\/dc19-1205","article-title":"CGM initiation soon after Type 1 diabetes diagnosis results in sustained CGM use and wear time","volume":"43","author":"Prahalad","year":"2020","journal-title":"Diabetes Care"},{"key":"R29-20250730","doi-asserted-by":"crossref","first-page":"e14567","DOI":"10.1111\/dme.14567","article-title":"\u2019I was ready for it at the beginning\u2019: parent experiences with early introduction of continuous glucose monitoring following their child's Type 1 diabetes diagnosis","volume":"38","author":"Tanenbaum","year":"2021","journal-title":"Diabet Med"},{"key":"R30-20250730","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/pedi.13293","article-title":"Does introduction of continuous glucose monitoring at diagnosis of type 1 diabetes increase uptake in children and adolescents?","volume":"23","author":"Hobbs","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"R31-20250730","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1089\/dia.2018.0257","article-title":"Glycemic outcomes with early initiation of continuous glucose monitoring system in recently diagnosed patients with Type 1 diabetes","volume":"21","author":"Mulinacci","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"R32-20250730","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/dia.2019.0026","article-title":"Early initiation of diabetes devices relates to improved glycemic control in children with recent-onset Type 1 diabetes mellitus","volume":"21","author":"Patton","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"R33-20250730","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1210\/clinem\/dgab859","article-title":"Teamwork, targets, technology, and tight control in newly diagnosed Type 1 diabetes: pilot 4T study","volume":"107","author":"Prahalad","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"R34-20250730","doi-asserted-by":"crossref","first-page":"595735","DOI":"10.3389\/fendo.2020.595735","article-title":"Glycemic control improvement in Italian children and adolescents with Type 1 diabetes followed through telemedicine during lockdown due to the COVID-19 pandemic","volume":"11","author":"Predieri","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R35-20250730","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1089\/dia.2021.0131","article-title":"Youth with Type 1 diabetes had improvement in continuous glucose monitoring metrics during the COVID-19 pandemic","volume":"23","author":"Abdulhussein","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"R36-20250730","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1089\/dia.2021.0258","article-title":"Improvement in mean CGM glucose in young people with Type 1 diabetes during 1 year of the COVID-19 pandemic","volume":"24","author":"Kaushal","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"R37-20250730","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/dia.2020.0375","article-title":"The Digital\/Virtual Diabetes Clinic: the future is now-recommendations from an international panel on Diabetes Digital Technologies Introduction","volume":"23","author":"Phillip","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"R38-20250730","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/dia.2018.0310","article-title":"The relationship of hemoglobin A1C to time-in-range in patients with diabetes","volume":"21","author":"Vigersky","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"R39-20250730","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1056-8727(01)00227-6","article-title":"High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control","volume":"16","author":"Hempe","year":"2002","journal-title":"J Diabetes Complications"},{"key":"R40-20250730","doi-asserted-by":"crossref","first-page":"108032","DOI":"10.1016\/j.diabres.2020.108032","article-title":"Glycemic variability modifies the relationship between time in range and hemoglobin A1c estimated from continuous glucose monitoring: a preliminary study","volume":"161","author":"Lu","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"R41-20250730","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1089\/dia.2018.0331","article-title":"Pediatric Endocrinology Trainees\u2019 education and knowledge about insulin pumps and continuous glucose monitors","volume":"21","author":"Marks","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"R42-20250730","first-page":"19322968221077132","article-title":"An opportunity for improvement: evaluation of diabetes technology education among Adult Endocrinology Training Programs","author":"Fantasia","year":"2022","journal-title":"J Diabetes Sci Technol"},{"key":"R43-20250730","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/pedi.13010","article-title":"Improving pediatric endocrinology trainees\u2019 knowledge about insulin pumps and continuous glucose monitors with online spaced education: Technology Knowledge Optimization in T1D (TeKnO T1D)","volume":"21","author":"Marks","year":"2020","journal-title":"Pediatr Diabetes"},{"key":"R44-20250730","doi-asserted-by":"crossref","first-page":"e4007","DOI":"10.1210\/clinem\/dgab409","article-title":"Use of continuous glucose monitor in critically Ill COVID-19 patients requiring insulin infusion: an observational study","volume":"106","author":"Faulds","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"R45-20250730","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2337\/dc20-2219","article-title":"Continuous glucose monitoring in the intensive care unit during the COVID-19 pandemic","volume":"44","author":"Agarwal","year":"2021","journal-title":"Diabetes Care"},{"key":"R46-20250730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MED.0000000000000693","article-title":"Continuous glucose monitoring in the hospital: an update in the era of COVID-19","volume":"29","author":"Gothong","year":"2022","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"R47-20250730","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2337\/dc20-2085","article-title":"Remote continuous glucose monitoring with a computerized insulin infusion protocol for critically ill patients in a COVID-19 medical ICU: proof of concept","volume":"44","author":"Davis","year":"2021","journal-title":"Diabetes Care"},{"key":"R48-20250730","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/1932296820906214","article-title":"Pediatric Medicaid patients with Type 1 diabetes benefit from continuous glucose monitor technology","volume":"15","author":"Ravi","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"R49-20250730","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2337\/dc20-1663","article-title":"Racial and ethnic disparities in rates of continuous glucose monitor initiation and continued use in children with Type 1 diabetes","volume":"44","author":"Lai","year":"2021","journal-title":"Diabetes Care"},{"key":"R50-20250730","first-page":"763","article-title":"Early racial\/ethnic disparities in continuous glucose monitor use in pediatric Type 1 diabetes","volume":"23","author":"Lai","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"R51-20250730","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/pedi.13082","article-title":"Uninterrupted continuous glucose monitoring access is associated with a decrease in HbA1c in youth with type 1 diabetes and public insurance","volume":"21","author":"Addala","year":"2020","journal-title":"Pediatr Diabetes"},{"key":"R52-20250730","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/pedi.13106","article-title":"Has subsidized continuous glucose monitoring improved outcomes in pediatric diabetes?","volume":"21","author":"Swaney","year":"2020","journal-title":"Pediatr Diabetes"},{"key":"R53-20250730","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/pedi.13150","article-title":"Fear of hypoglycemia in children with type 1 diabetes and their parents: Effect of pump therapy and continuous glucose monitoring with option of low glucose suspend in the CGM TIME trial","volume":"22","author":"Verbeeten","year":"2021","journal-title":"Pediatr Diabetes"},{"key":"R54-20250730","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(20)32514-9","article-title":"A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial","volume":"397","author":"Bergenstal","year":"2021","journal-title":"Lancet"},{"key":"R55-20250730","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJMoa2004736","article-title":"A randomized trial of closed-loop control in children with Type 1 diabetes","volume":"383","author":"Breton","year":"2020","journal-title":"N Engl J Med"},{"key":"R56-20250730","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMoa2111673","article-title":"Randomized trial of closed-loop control in very young children with Type 1 diabetes","volume":"386","author":"Ware","year":"2022","journal-title":"N Engl J Med"},{"key":"R57-20250730","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/pedi.12410","article-title":"Ketone production in children with type 1 diabetes, ages 4-14\u200ayears, with and without nocturnal insulin pump suspension","volume":"18","author":"Wadwa","year":"2017","journal-title":"Pediatr Diabetes"},{"key":"R58-20250730","doi-asserted-by":"crossref","first-page":"e1345","DOI":"10.1097\/PEC.0000000000002035","article-title":"Plasma beta-hydroxybutyrate for the diagnosis of diabetic ketoacidosis in the emergency department","volume":"37","author":"Tremblay","year":"2021","journal-title":"Pediatr Emerg Care"},{"key":"R59-20250730","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1177\/19322968211008185","article-title":"Feasibility of continuous ketone monitoring in subcutaneous tissue using a ketone sensor","volume":"15","author":"Alva","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"R60-20250730","first-page":"19322968211042656","article-title":"Continuous Ketone Monitoring Consensus Report 2021","author":"Nguyen","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"R61-20250730","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1089\/dia.2018.0143","article-title":"Performance of a factory-calibrated real-time continuous glucose monitoring system utilizing an automated sensor applicator","volume":"20","author":"Shah","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"R62-20250730","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1089\/dia.2017.0087","article-title":"Accuracy of a fourth-generation subcutaneous continuous glucose sensor","volume":"19","author":"Christiansen","year":"2017","journal-title":"Diabetes Technol Ther"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:12:46Z","timestamp":1753899166000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001136","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"type":"print","value":"1040-8703"},{"type":"electronic","value":"1531-698X"}],"subject":[],"published":{"date-parts":[[2022,8]]}}}